Ocugen, Inc. (OCGN) Financials
OCGN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 74.7 million | 16.3 million |
2023-06-30 | 89.0 million | 18.7 million |
2023-03-31 | 96.3 million | 20.5 million |
2022-12-31 | 108.6 million | 24.6 million |
OCGN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -17.1 million | 2.2 million |
2023-06-30 | -21.6 million | 2.6 million |
2023-03-31 | -19.9 million | 2.7 million |
2022-12-31 | -18.9 million | 2.7 million |
OCGN Net Income
No data available :(
OCGN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 53.5 million | - | 3.7 million |
2023-06-30 | 70.6 million | 1.5 million | 3.8 million |
2023-03-31 | 76.7 million | 1.1 million | 4.0 million |
2022-12-31 | 90.9 million | - | 4.1 million |
OCGN Shares Outstanding
OCGN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 3.4 million | 6.3 million | 9.1 million | - |
2023-06-30 | 2.8 million | 14.2 million | 9.6 million | - |
2023-03-31 | 1.6 million | 9.6 million | 8.2 million | - |
2022-12-31 | 2.0 million | 17.2 million | 6.9 million | - |
OCGN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 177000 |
2023-06-30 | - | 308000 |
2023-03-31 | - | 305000 |
2022-12-31 | - | 303000 |
OCGN
Price: $1.28
52 week price:
Earnings Per Share: -0.32 USD
P/E Ratio: -1.68
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 4.7 million
Market Capitalization: 469.4 million